Received Mar 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | W026152 | — |
No additional AE/PQC reported; Customer called to report expired GARDASIL 9 administered to a patient post product expiration. Expiration date was 29JAN2025. Product was administered on 14MAR2025. No TE occurred. No symptoms reported. Caller consented to correspondence. See r; This spontaneous report was received from a nurse, concerning to a 34-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 14-Mar-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant, at a dose of 0.5 mL, administered as prophylaxis (route of administration was not provided; lot #W026152 has been verified to be valid for this vaccine, expiration date reported and confirmed as 29-Jan-2025); which was an expired vaccine (Expired product administered). No additional adverse event was reported (No adverse event).